Disseminated bcg disease associated with immunotherapy by scarification in acute leukemia
- 1 July 1978
- Vol. 42 (1) , 167-170
- https://doi.org/10.1002/1097-0142(197807)42:1<167::aid-cncr2820420128>3.0.co;2-d
Abstract
Disseminated BCG infection developed in a patient with acute leukemia receiving BCG immunotherapy by scarification. Predisposing factors included the underlying malignancy, intensive chemotherapy, and continuous high-dose corticosteroids. The scarification technique is safe; however, physicians should be alert to this syndrome as a cause of fever of unknown origin in cancer patients receiving BCG immunotherapy.This publication has 29 references indexed in Scilit:
- Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.BMJ, 1976
- PROLONGATION OF POSTOPERATIVE DISEASE-FREE INTERVAL AND SURVIVAL IN HUMAN COLORECTAL CANCER BY B.C.G. OR B.C.G. PLUS 5-FLUOROURACILThe Lancet, 1976
- Immunotherapy of melanoma with BCG: Two fatalities following intralesional injectionCancer, 1975
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- RESULTS OF ADMINISTERING B.C.G. TO PATIENTS WITH MELANOMAThe Lancet, 1974
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- GENERALIZED BCG TUBERCULOSIS WITH FATAL COURSE IN TWO SISTERSActa Paediatrica, 1972
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Fatal BCG Infection in an Infant with Congenital, Lymphocytopenic AgammaglobulinemiaActa Paediatrica, 1966